| Direct costs | Total costs |
Cost-effectiveness ratios |
Difference in SGRQ total scores at 1-yr follow-up | 1839/16.3=113 | −5493/16.3=−337 |
FEV1, change in mL | 1839/195=9.4 | −5493/195=−28 |
FEV1, change in % | 1839/6.1=301 | −5493/6.1=−901 |
Adjusted cost-effectiveness ratios,, |
Difference in SGRQ total score at 1-yr follow-up | 1110/10 | −3400/10 |
FEV1, change in mL | 900/100 | −2800/100 |
FEV1, change in % | 1500/5 | −4500/5 |
Cost-effectiveness ratio/per % of patients having: |
A better year | 1839/38=48 | −5493/38=−145 |
Symptom free days | 1839/45=41 | −5493/45=−122 |
Symptom free nights | 1839/34=54 | −5493/34=−162 |
No impact on daily life | 1839/26=71 | −5493/26=−211 |
The cost of making one person have, |
A better year | 4800 | −14400 |
Symptom free days | 4100 | −12200 |
Symptom free nights | 5400 | −16100 |
No impact on daily life | 7100 | −21100 |